mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |